BMSC-derived exosomes protect against kidney injury through regulating klotho in 5/6 nephrectomy rats
Authors:
Open Access
- 11 July 2022
- journal article
- research article
- Published by Springer Nature in European Journal of Medical Research
- Vol. 27 (1) , 1-9
Abstract
Aim: The aim of this study was to investigate the renoprotective effects of exosomes derived from rat bone marrow mesenchymal stem cells (rBMSCs) in a rat model of 5/6 nephrectomy (Nx)-induced chronic kidney disease (CKD). Methods: A rat model of 5/6 Nx-induced CKD was established using conventional method. rBMSC-derived exosomes were isolated using ultracentrifugation and characterized. The exosomes were injected into 5/6 Nx rats through the caudal vein. After 12 weeks, 24 h proteinuria, serum creatinine (SCr), and blood urea nitrogen (BUN) levels were evaluated, and renal pathology was analyzed by H&E and Masson staining, and transmission electron microscopy. The expression of klotho was analyzed and the activity of the klotho promoter was evaluated using a luciferase reporter assay. Results: The isolated exosomes showed typical morphological features. Exosomes transplantation reduced 24 h urinary protein excretion, and SCr and BUN levels in 5/6 Nx-induced CKD rats. Furthermore, renal pathology was improved in the exosome-treated 5/6 Nx rats. Mechanistically, the exosomes significantly upregulated the activity of klotho promoter and its expression. Conclusions: Transplantation of rBMSC-derived exosomes may protect against kidney injury, probably by regulating klotho activity and expression. Our results provide a theoretical basis for the application of rBMSC-derived exosomes in CKD therapy.Keywords
Funding Information
- Public Welfare Technology Application Research Program of Zhejiang Province (LGC21H290002)
- Natural Science Foundation of Zhejiang Province (Y20H050004, LQ21H290005)
This publication has 29 references indexed in Scilit:
- Stem cell therapy for kidney diseaseExpert Opinion on Biological Therapy, 2015
- Soluble α-Klotho as a Novel Biomarker in the Early Stage of Nephropathy in Patients with Type 2 DiabetesPLOS ONE, 2014
- Genetic Deficiency of Anti-Aging Gene Klotho Exacerbates Early Nephropathy in STZ-Induced Diabetes in Male MiceEndocrinology, 2013
- MicroRNA-339 and microRNA-556 regulate Klotho expression in vitroAGE, 2013
- Klotho as a potential biomarker and therapy for acute kidney injuryNature Reviews Nephrology, 2012
- Mesenchymal stem cells in kidney inflammation and repairNephrology, 2011
- Warfarin-Related Nephropathy Modeled by Nephron Reduction and Excessive AnticoagulationJournal of the American Society of Nephrology, 2011
- Klotho deficiency is an early biomarker of renal ischemia–reperfusion injury and its replacement is protectiveKidney International, 2010
- Systemic Administration of Multipotent Mesenchymal Stromal Cells Reverts Hyperglycemia and Prevents Nephropathy in Type 1 Diabetic MiceTransplantation and Cellular Therapy, 2008
- Human Bone Marrow Mesenchymal Stem Cells Accelerate Recovery of Acute Renal Injury and Prolong Survival in MiceStem Cells, 2008